Kazia Therapeutics KZIA
NASDAQ KZIA
$9.60 -0.15 (-1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Net Margin (2009 - 2016)

Updated

Kazia Therapeutics (KZIA) posted Net Margin of -49345.24% for the year ended Jun 30, 2025, down 48184.67 percentage points from -1160.57% a year earlier.

Analysis

Kazia Therapeutics (KZIA) Net Margin (2009 - 2016) Analysis & Trends

Since the year ended Jun 30, 2009, Kazia Therapeutics has reported Net Margin for 13 years.

  • Annual Net Margin shows a four-year change of -49289.78 percentage points (years ended Jun 2021 to Jun 2025).
  • The figure for the year ended Jun 30, 2025 stands as the lowest annual Net Margin in data going back to the year ended Jun 30, 2009.
  • Business Quant data shows KZIA's Net Margin at -1160.57% in the year ended Jun 30, 2024 and -55.46% in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Kazia Therapeutics 70.77 Mn 70.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 -298.51%
Dec 31, 2013 -190.35%
Aug 30, 2013 -123.39%
Dec 31, 2012 104.05%
Dec 31, 2009 -6,428.92%
API Access

Kazia Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY